Debt-to-equity stands at 0.78 with total debt of $6.8B, while cash has thinned to $141.8M, indicating a reliance on operating cash flow and a need to monitor liquidity.
Labcorp Holdings Inc. (LH) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 3.81B | 4.02B | 4.81B | 3.77B | 4.63B | 5.33B | 5.13B | 2.98B | 2.84B | 2.68B | 2.48B | 2.66B | 1.69B | 1.19B | 1.19B | 859.1M | 1.14B | 935.6M | 1.03B | 937.5M | 887M | 702.3M | 740M | 657.9M | 596.7M | 624.5M | 511.7M | 499.5M | 519.1M | 527.6M | 721.5M |
| Cash & Short-Term Investments | 141.8M | 532.3M | 1.52B | 536.8M | 320.6M | 1.47B | 1.32B | 337.5M | 426.8M | 316.7M | 433.6M | 716.4M | 580M | 404M | 466.8M | 159.3M | 230.7M | 148.5M | 219.7M | 166.3M | 186.9M | 63.1M | 206.8M | 123M | 56.4M | 149.2M | 48.8M | 40.3M | 22.7M | 23.3M | 29.3M |
| Cash Only | 141.8M | 532.3M | 1.52B | 536.8M | 320.6M | 1.47B | 1.32B | 337.5M | 426.8M | 316.6M | 433.6M | 716.4M | 580M | 404M | 466.8M | 159.3M | 230.7M | 148.5M | 219.7M | 56.4M | 51.5M | 45.4M | 186.8M | 123M | 56.4M | 149.2M | 48.8M | 40.3M | 22.7M | 23.3M | 29.3M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 109.9M | 135.4M | 17.7M | 20M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 2.5B | 2.26B | 2.1B | 2.1B | 2B | 2.98B | 3.02B | 2.03B | 1.86B | 1.85B | 1.52B | 1.37B | 815.7M | 784.7M | 718.5M | 699.8M | 655.6M | 574.2M | 631.6M | 623.2M | 541.3M | 493.4M | 441.4M | 432.5M | 393M | 365.5M | 368M | 348M | 375.4M | 330.6M | 505.6M |
| Days Sales Outstanding | 60.3 | 59.14 | 58.84 | 62.99 | 61.45 | 82.76 | 78.77 | 63.98 | 59.98 | 64.58 | 57.49 | 57.8 | 49.53 | 49.31 | 46.24 | 46.09 | 47.82 | 44.64 | 51.17 | 55.91 | 55.02 | 54.12 | 52.23 | 53.71 | 57.2 | 60.65 | 69.98 | 74.77 | 84.97 | 79.44 | 114.79 |
| Inventory | 562.2M | 534.7M | 493.2M | 474.6M | 470.6M | 401.4M | 423.2M | 244.7M | 237.3M | 227.6M | 205.2M | 191M | 139.5M | 136.5M | 121M | 110.8M | 103.4M | 90M | 91M | 80.4M | 84.3M | 65.4M | 61.5M | 47M | 44.8M | 38.7M | 31.6M | 29.1M | 30.7M | 36M | 44.3M |
| Days Inventory Outstanding | 18.65 | 19.1 | 19.18 | 19.69 | 21.06 | 17.99 | 17.11 | 10.76 | 10.62 | 11.91 | 11.59 | 12.07 | 13.37 | 13.9 | 12.91 | 12.38 | 12.99 | 12.06 | 12.62 | 12.35 | 14.93 | 12.32 | 12.5 | 10 | 11.31 | 11.09 | 10.52 | 10.45 | 11.25 | 12.83 | 14.32 |
| Other Current Assets | 606.1M | 1 | 697.6M | 655.3M | 1.84B | 0 | 0 | 0 | 0 | 88.9M | 148.3M | 164.9M | 0 | 106.9M | 85.5M | 114.9M | 58.4M | 42.8M | 6.7M | 0 | 21.3M | 43.2M | 1.1M | 19.1M | 57.1M | 54.4M | 63.3M | 82.1M | 90.3M | 137.7M | 142.3M |
| Total Non-Current Assets | 14.72B | 14.37B | 13.57B | 12.96B | 15.53B | 15.05B | 14.95B | 15.04B | 13.35B | 13.89B | 11.77B | 11.62B | 5.61B | 5.76B | 5.62B | 5.31B | 5.04B | 3.9B | 3.64B | 3.43B | 3.11B | 3.17B | 2.86B | 2.76B | 2.02B | 1.31B | 1.16B | 1.09B | 1.12B | 1.13B | 1.2B |
| Property, Plant & Equipment | 3.1B | 3.08B | 3.05B | 2.91B | 2.79B | 2.82B | 2.73B | 2.61B | 1.78B | 1.75B | 1.72B | 1.75B | 786.5M | 707.4M | 630.8M | 578.3M | 586.9M | 500.8M | 496.4M | 439.2M | 393.2M | 381.5M | 360M | 361.3M | 351.2M | 309.3M | 272.8M | 273.2M | 259.1M | 254.9M | 282.9M |
| Fixed Asset Turnover | 4.64x | 4.53x | 4.27x | 4.18x | 4.25x | 4.67x | 5.12x | 4.42x | 6.35x | 5.97x | 5.61x | 4.97x | 7.64x | 8.21x | 8.99x | 9.58x | 8.53x | 9.37x | 9.08x | 9.26x | 9.13x | 8.72x | 8.57x | 8.14x | 7.14x | 7.11x | 7.04x | 6.22x | 6.22x | 5.96x | 5.68x |
| Goodwill | 7.03B | 6.79B | 6.37B | 6.14B | 6.12B | 7.96B | 7.75B | 7.87B | 7.36B | 7.53B | 6.42B | 6.29B | 3.1B | 3.02B | 2.9B | 2.68B | 2.6B | 1.9B | 1.77B | 1.64B | 1.48B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 3.68B | 3.6B | 3.49B | 3.34B | 3.12B | 3.74B | 3.96B | 4.03B | 3.91B | 4.34B | 3.4B | 3.32B | 1.48B | 1.57B | 1.67B | 1.62B | 1.67B | 1.34B | 1.22B | 613.4M | 610.2M | 2.12B | 1.86B | 1.86B | 1.22B | 968.5M | 865.7M | 803.9M | 836.2M | 851.3M | 891.1M |
| Long-Term Investments | 608M | 153.9M | 16.3M | 26.9M | 65.7M | 60.9M | 73.5M | 84.9M | 60.5M | 58.4M | 57.6M | 58.2M | 92.6M | 88.5M | 78.1M | 76.8M | 78.5M | 71.4M | 72M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 769.3M | 751.3M | 652.2M | 536.5M | 3.42B | 462.6M | 410M | 435.4M | 276M | 605.3M | 165.1M | 150M | 154.8M | 143.1M | 124.9M | 94.2M | 103.2M | 90.7M | 73.5M | 738.6M | 626.4M | 669.3M | 643.5M | 538.4M | 426.6M | 27.3M | 16.7M | 13.6M | 26.5M | 24.7M | 21.5M |
| Total Assets | 18.53B | 18.39B | 18.38B | 16.73B | 20.16B | 20.39B | 20.07B | 18.02B | 16.19B | 16.57B | 14.25B | 14.29B | 7.3B | 6.95B | 6.81B | 6.17B | 6.19B | 4.84B | 4.67B | 4.37B | 4B | 3.88B | 3.6B | 3.41B | 2.61B | 1.93B | 1.67B | 1.59B | 1.64B | 1.66B | 1.92B |
| Asset Turnover | 0.77x | 0.76x | 0.71x | 0.73x | 0.59x | 0.64x | 0.70x | 0.64x | 0.70x | 0.63x | 0.68x | 0.61x | 0.82x | 0.84x | 0.83x | 0.90x | 0.81x | 0.97x | 0.96x | 0.93x | 0.90x | 0.86x | 0.86x | 0.86x | 0.96x | 1.14x | 1.15x | 1.07x | 0.98x | 0.92x | 0.84x |
| Asset Growth % | 9.23% | 0.07% | 9.89% | -17.02% | -1.13% | 1.56% | 11.38% | 11.34% | -2.31% | 16.29% | -0.27% | 95.65% | 5.07% | 2.05% | 10.35% | -0.27% | 27.91% | 3.6% | 6.9% | 9.18% | 3.23% | 7.63% | 5.45% | 30.75% | 35.35% | 15.76% | 4.82% | -3.09% | -1.06% | -13.48% | 4.34% |
| Total Current Liabilities | 2.12B | 2.82B | 3.33B | 3.23B | 3.08B | 2.78B | 3.08B | 2.66B | 1.88B | 2.19B | 1.83B | 1.7B | 976.3M | 735.7M | 1.03B | 732.6M | 1.12B | 1.02B | 546.9M | 967.9M | 930.9M | 888.1M | 300.8M | 757.6M | 226.4M | 201.2M | 311.9M | 245.6M | 251.4M | 196.6M | 252.8M |
| Accounts Payable | 688.5M | 840.8M | 875.8M | 827.5M | 852.2M | 621.3M | 638.9M | 632.3M | 634.6M | 573.9M | 508.4M | 497.4M | 282.3M | 304.5M | 236.9M | 257.8M | 257.8M | 183.1M | 159.7M | 134.2M | 133.5M | 116.2M | 85.3M | 73M | 79.9M | 60.2M | 52.8M | 43.6M | 50.2M | 55.9M | 65.7M |
| Days Payables Outstanding | 25.51 | 30.03 | 34.06 | 34.34 | 38.14 | 27.85 | 25.84 | 27.8 | 28.4 | 30.02 | 28.72 | 31.43 | 27.06 | 31 | 25.27 | 28.8 | 32.38 | 24.54 | 22.15 | 20.61 | 23.64 | 21.89 | 17.34 | 15.54 | 20.17 | 17.24 | 17.57 | 15.66 | 18.4 | 19.92 | 21.24 |
| Short-Term Debt | 900K | 695.8M | 1B | 999.8M | 301.3M | 1.5M | 376.7M | 415.2M | 10M | 409.2M | 541.1M | 418.5M | 343.9M | 110.8M | 480M | 135.5M | 361.7M | 417.2M | 120.8M | 589.5M | 554.4M | 544.6M | 100K | 523.5M | 400K | 0 | 132M | 95M | 72.5M | 0 | 18.7M |
| Deferred Revenue (Current) | 1.62B | 439.1M | 392.2M | 421.7M | 310.6M | 558.5M | 506.5M | 451M | 356.4M | 380.8M | 176M | 146.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 847.8M | 495.4M | 431.4M | 1.1B | 735.5M | 623.2M | 474.6M | 427.6M | 432.8M | 346.2M | 353.7M | 204.2M | 199.4M | 177.9M | 188.9M | 148.1M | 142.4M | 0 | 9.9M | 7.7M | 0 | 0 | 0 | 0 | 0 | 127.1M | 107M | 128.7M | 140.7M | 168.4M |
| Current Ratio | 1.80x | 1.42x | 1.44x | 1.17x | 1.50x | 1.92x | 1.66x | 1.12x | 1.51x | 1.23x | 1.36x | 1.57x | 1.73x | 1.62x | 1.15x | 1.17x | 1.02x | 0.92x | 1.89x | 0.97x | 0.95x | 0.79x | 2.46x | 0.87x | 2.64x | 3.10x | 1.64x | 2.03x | 2.06x | 2.68x | 2.85x |
| Quick Ratio | 1.53x | 1.23x | 1.30x | 1.02x | 1.35x | 1.77x | 1.53x | 1.03x | 1.38x | 1.12x | 1.24x | 1.45x | 1.59x | 1.43x | 1.03x | 1.02x | 0.93x | 0.83x | 1.72x | 0.89x | 0.86x | 0.72x | 2.26x | 0.81x | 2.44x | 2.91x | 1.54x | 1.92x | 1.94x | 2.50x | 2.68x |
| Cash Conversion Cycle | 53.45 | 48.21 | 43.96 | 48.34 | 44.37 | 72.9 | 70.05 | 46.94 | 42.2 | 46.47 | 40.36 | 38.44 | 35.84 | 32.21 | 33.88 | 29.67 | 28.43 | 32.17 | 41.64 | 47.65 | 46.31 | 44.55 | 47.39 | 48.17 | 48.34 | 54.49 | 62.93 | 69.57 | 77.82 | 72.35 | 107.87 |
| Total Non-Current Liabilities | 7.78B | 6.93B | 6.98B | 5.61B | 6.96B | 7.31B | 7.54B | 7.8B | 7.32B | 7.66B | 6.9B | 7.44B | 3.49B | 3.72B | 3.03B | 2.86B | 2.58B | 1.71B | 2.31B | 1.68B | 1.09B | 1.1B | 1.33B | 761.4M | 742.3M | 643M | 477.6M | 610.4M | 708.3M | 831.9M | 1.41B |
| Long-Term Debt | 5.86B | 5.77B | 5.33B | 4.05B | 5.04B | 5.42B | 5.42B | 5.79B | 5.99B | 6.29B | 5.24B | 5.88B | 2.64B | 2.88B | 2.17B | 2.09B | 1.83B | 977.2M | 1.6B | 1.08B | 603M | 604.5M | 889.3M | 356.3M | 516M | 502.8M | 353.7M | 482.8M | 575.5M | 689.6M | 1.26B |
| Capital Lease Obligations | 2.94B | 745.6M | 750.6M | 727.5M | 736.5M | 727.1M | 762M | 687.7M | 51M | 57.8M | 56.2M | 55.5M | 39.2M | 14.1M | 0 | -5.9M | 0 | 0 | 0 | 0 | 0 | 0 | 2.9M | 4.4M | 5.5M | 6.1M | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 1.84B | 454.5M | 383.1M | 417.9M | 543.4M | 762.9M | 828.5M | 942.8M | 940M | 875.5M | 1.21B | 1.18B | 530.4M | 563.9M | 546M | 477.9M | 602.3M | 577.7M | 522.9M | 506.8M | 409.2M | 408.9M | 346.2M | 273.4M | 79.3M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 717.6M | -34.8M | 517.4M | 409.3M | 642.4M | 402M | 526.4M | 383.2M | 334M | 442.3M | 392M | 320.6M | 270.8M | 262.5M | 302M | 286.2M | 151.4M | 158.4M | 189.6M | 90.7M | 80.6M | 88.6M | 87.6M | 127.3M | 141.5M | 134.1M | 123.9M | 127.6M | 132.8M | 142.3M | 144.5M |
| Total Liabilities | 9.91B | 9.76B | 10.31B | 8.83B | 10.04B | 10.09B | 10.61B | 10.46B | 9.19B | 9.85B | 8.73B | 9.14B | 4.46B | 4.46B | 4.06B | 3.59B | 3.7B | 2.73B | 2.86B | 2.64B | 2.02B | 1.99B | 1.63B | 1.52B | 968.7M | 844.2M | 789.5M | 856M | 959.7M | 1.03B | 1.66B |
| Total Debt | 6.77B | 7.2B | 7.27B | 5.95B | 6.25B | 6.34B | 6.76B | 7.11B | 6.06B | 6.76B | 5.85B | 6.36B | 3.03B | 3B | 2.65B | 2.22B | 2.19B | 1.39B | 1.72B | 1.67B | 1.16B | 1.15B | 892.3M | 884.2M | 521.9M | 508.9M | 485.7M | 577.8M | 648M | 689.6M | 1.28B |
| Net Debt | 6.62B | 6.67B | 5.75B | 5.42B | 5.93B | 4.87B | 5.44B | 6.77B | 5.63B | 6.45B | 5.42B | 5.65B | 2.45B | 2.6B | 2.19B | 2.06B | 1.96B | 1.25B | 1.5B | 1.61B | 1.11B | 1.1B | 705.5M | 761.2M | 465.5M | 359.7M | 436.9M | 537.5M | 625.3M | 666.3M | 1.25B |
| Debt / Equity | 0.78x | 0.83x | 0.90x | 0.75x | 0.62x | 0.62x | 0.71x | 0.94x | 0.87x | 0.99x | 1.06x | 1.28x | 1.07x | 1.20x | 0.97x | 0.88x | 0.88x | 0.66x | 0.95x | 0.97x | 0.59x | 0.61x | 0.45x | 0.47x | 0.32x | 0.47x | 0.55x | 0.79x | 0.95x | 1.09x | 4.96x |
| Debt / EBITDA | 2.92x | 3.28x | 4.20x | 4.57x | 3.16x | 1.75x | 2.07x | 3.38x | 3.23x | 3.56x | 3.24x | 4.36x | 2.62x | 2.80x | 2.39x | 2.15x | 2.08x | 1.40x | 1.91x | 1.77x | 1.36x | 1.50x | 1.21x | 1.32x | 0.97x | 1.08x | 1.43x | 2.47x | 3.06x | - | - |
| Net Debt / EBITDA | 2.86x | 3.04x | 3.33x | 4.16x | 3.00x | 1.34x | 1.66x | 3.22x | 3.00x | 3.40x | 3.00x | 3.87x | 2.12x | 2.42x | 1.97x | 1.99x | 1.86x | 1.25x | 1.67x | 1.71x | 1.30x | 1.44x | 0.96x | 1.14x | 0.87x | 0.76x | 1.29x | 2.30x | 2.95x | - | - |
| Interest Coverage | 6.41x | 5.94x | 5.61x | 3.85x | 7.88x | 14.63x | 11.70x | 5.59x | 6.19x | 5.58x | 6.02x | 3.64x | 8.49x | 10.49x | 10.99x | 10.90x | 14.08x | 15.06x | 11.91x | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 8.62B | 8.64B | 8.07B | 7.89B | 10.12B | 10.29B | 9.46B | 7.59B | 6.99B | 6.82B | 5.52B | 4.96B | 2.84B | 2.51B | 2.74B | 2.52B | 2.49B | 2.11B | 1.81B | 1.73B | 1.98B | 1.89B | 2B | 1.9B | 1.61B | 1.09B | 877.4M | 734.2M | 681.2M | 630M | 258.1M |
| Equity Growth % | 20.18% | 7.07% | 2.23% | -22% | -1.73% | 8.85% | 24.65% | 8.53% | 2.43% | 23.62% | 11.31% | 74.76% | 13.04% | -8.3% | 8.5% | 1.48% | 18.08% | 16.38% | 4.89% | -12.74% | 4.85% | -5.68% | 5.45% | 17.63% | 48.49% | 23.71% | 19.5% | 7.78% | 8.13% | 144.09% | -37.29% |
| Book Value per Share | 105.16 | 103.06 | 95.57 | 90.07 | 110.43 | 105.58 | 96.50 | 76.95 | 68.13 | 65.69 | 52.93 | 49.30 | 32.85 | 27.35 | 28.11 | 24.79 | 23.59 | 19.30 | 15.99 | 14.22 | 14.84 | 13.23 | 13.49 | 12.46 | 11.20 | 7.68 | 15.63 | 13.48 | 13.52 | 12.81 | 5.25 |
| Total Shareholders' Equity | 8.61B | 8.62B | 8.05B | 7.88B | 10.1B | 10.27B | 9.44B | 7.57B | 6.97B | 6.8B | 5.51B | 4.95B | 2.82B | 2.49B | 2.72B | 2.5B | 2.47B | 2.11B | 1.69B | 1.73B | 1.98B | 1.89B | 2B | 1.9B | 1.61B | 1.09B | 877.4M | 734.2M | 681.2M | 630M | 258.1M |
| Common Stock | 7.3M | 7.5M | 7.6M | 7.7M | 8.1M | 8.5M | 9M | 9M | 11.7M | 12M | 12.1M | 12M | 10.4M | 10.5M | 11.3M | 11.7M | 12.2M | 12.5M | 12.8M | 13.2M | 14.4M | 14.8M | 15.1M | 14.9M | 14.8M | 7.1M | 3.5M | 1.3M | 0 | 0 | 0 |
| Retained Earnings | 8.7B | 8.64B | 8.3B | 7.89B | 10.58B | 10.46B | 9.48B | 7.9B | 7.08B | 6.22B | 4.96B | 4.22B | 3.79B | 3.37B | 3.59B | 3.39B | 3.25B | 2.93B | 2.6B | 2.24B | 1.77B | 1.34B | 950.1M | 587.1M | 266.1M | 11.5M | -168M | -245.5M | -260.5M | -284.9M | -154.1M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.11B | -1.06B | -1.01B | -978.1M | -965.5M | -958.9M | -951.8M | -940.9M | -934.9M | -932.5M | -929.8M | -897.1M | -891.6M | -888.5M | -544.2M | -159.3M | -4.4M | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -101.9M | -27.6M | -261.6M | -59.3M | -493.2M | -192M | -161.9M | -372.4M | -463.1M | -335.7M | -581.1M | -221.1M | -10.5M | 66.2M | 69.4M | 45.5M | 88.5M | 61.5M | -16.7M | 120M | 58.7M | 83.4M | 74.2M | 12.3M | -71.3M | -22M | -9.8M | -4.2M | -174.7M | -204.9M | -174.7M |
| Minority Interest | 16.4M | 16.9M | 14.3M | 15.5M | 18.9M | 20.6M | 20.7M | 20.1M | 19.1M | 20.8M | 15.2M | 14.9M | 17.7M | 19.4M | 20.7M | 20.2M | 20.6M | 0 | 121.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying LH stock.
As of 2025, Labcorp Holdings Inc. (LH) had total assets of $18.39B including $4.02B in current assets.
Labcorp Holdings Inc. (LH) carries total debt of $7.20B, offset by $532.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Labcorp Holdings Inc. (LH) has total shareholders' equity (book value) of $8.62B ($103.06 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Labcorp Holdings Inc. (LH) reported a current ratio of 1.42x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Regulatory LDT oversight
Metrics are mathematically derived from official filings.
Leverage Creeps Higher Amid Expansion
Total assets grew from $16.5B in 2024Q1 to $18.5B in 2026Q2, while debt-to-equity rose from 0.75 to 0.78, per recent SEC filings, indicating a balance sheet expanding with modest leverage.
The sequential increase in total assets, particularly in goodwill and PPE, suggests continued investment in acquisitions and infrastructure. However, the rise in D/E from 0.75 to 0.78 over the period, despite a slight dip in 2026Q1, implies that growth is partly debt-funded. This trend, coupled with the recent spin-off, may indicate a deliberate strategy to leverage the core diagnostics business, but investors should monitor whether this leverage remains within manageable bounds.
Debt Load Stabilizes After Spin-Off
Total debt hovered around $7.2B in 2025, then dipped to $6.8B in 2026Q2, with D/E at 0.78, as reported in financial statements, suggesting a deleveraging trend post-Fortrea spin-off.
The reduction in total debt from $7.3B in 2024Q4 to $6.8B in 2026Q2, alongside a stable equity base, indicates that management is prioritizing balance sheet strength. The D/E ratio of 0.78 remains below peer Quest's 0.95, suggesting a relatively conservative leverage profile. However, the absolute debt level of $6.8B still represents a significant fixed obligation, and with cash reserves of only $141.8M in 2026Q2, the company's liquidity buffer against debt servicing is thin, warranting close attention to cash flow generation.
Goodwill Dominates Asset Base
Goodwill rose from $6.2B in 2024Q1 to $7.0B in 2026Q2, now representing 38% of total assets, based on reported figures, highlighting the acquisitive nature of Labcorp's growth strategy.
The steady increase in goodwill, up $0.8B over the period, reflects a continued M&A-driven approach, consistent with management's historical 'bolt-on' strategy. While this has expanded the asset base, it also raises the risk of future impairment if acquired businesses underperform. In contrast, PPE has remained relatively flat at $3.1B, suggesting that organic capital expenditure is not keeping pace with acquisition-driven growth, which may indicate a reliance on acquisitions rather than internal investment for expansion.
Retained Earnings Steady, Buybacks Continue
Retained earnings grew from $8.1B in 2024Q1 to $8.7B in 2026Q2, while equity remained around $8.6B, as per recent financial statements, indicating a stable equity base despite ongoing share repurchases.
The modest increase in retained earnings, despite aggressive buybacks ($353.8M in 2026Q2 alone), suggests that net income is being partially offset by capital returns. The stability of total equity, hovering between $8.0B and $8.7B, implies that the company is effectively recycling earnings into buybacks and dividends rather than building a larger equity cushion. This approach may enhance shareholder returns but could also limit financial flexibility in a downturn.
Liquidity Cushion Thins to Multi-Year Low
Cash dropped from $1.5B in 2024Q4 to $141.8M in 2026Q2, while the current ratio improved to 1.80, according to recent SEC filings, suggesting a reliance on operating cash flow rather than cash reserves.
The dramatic decline in cash, from $1.5B to $141.8M, is striking, yet the current ratio has improved from 1.44 to 1.80, indicating that current assets are more than covering short-term liabilities. This paradox suggests that the company is deploying its cash into working capital and investments, possibly to fund growth. However, the thin cash position leaves little room for unexpected shocks, and the company may need to rely on credit lines or debt issuance if cash flow falters.
Deferred Revenue Signals Pipeline Strength
Deferred revenue remained stable around $390M over the past ten quarters, with 2026Q2 at $387.8M, as reported in financial statements, suggesting a consistent backlog of services yet to be recognized.
The stability of deferred revenue, despite the spin-off and revenue growth, implies that the company's contract-based revenue streams are not expanding significantly. This could indicate that the growth is driven more by transactional volume than by long-term contracts, which may be less predictable. Investors should monitor whether deferred revenue grows in line with revenue, as a divergence could signal changes in the business mix or contract terms.